Literature DB >> 3384086

Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes.

S M Moghimi1, H M Patel.   

Abstract

In accordance with the finding of our in vivo experiments reported earlier [(1983) Biochim. Biophys. Acta 761, 142-157; (1986) Biochim. Biophys. Acta 888, 184-190], the results of in vitro experiments show that Kupffer cells avidly take up cholesterol-poor but not cholesterol-rich liposomes, whereas splenic phagocytic cells take up preferentially cholesterol-rich rather than cholesterol-poor liposomes in the presence of serum. Evidence presented here suggests that serum contains opsonins specific for hepatic and splenic phagocytic cells and these opsonins have different affinities for cholesterol-rich and cholesterol-poor liposomes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384086     DOI: 10.1016/0014-5793(88)81372-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer's patch targeting using a polyplex-loaded liposomes.

Authors:  Sunee Channarong; Wanpen Chaicumpa; Nuttanan Sinchaipanid; Ampol Mitrevej
Journal:  AAPS PharmSciTech       Date:  2010-12-31       Impact factor: 3.246

3.  Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis.

Authors:  W G Love; N Amos; I W Kellaway; B D Williams
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

4.  Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles.

Authors:  Heena V Maithania; Bhabani S Mohanty; Pradip R Chaudhari; Abdul Samad; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 5.  Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential.

Authors:  Anil B Jindal
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

6.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

7.  Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus.

Authors:  A I Vitas; R Díaz; C Gamazo
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

8.  Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery.

Authors:  Yuan Wan; Lixue Wang; Chuandong Zhu; Qin Zheng; Guoxiang Wang; Jinlong Tong; Yuan Fang; Yiqiu Xia; Gong Cheng; Xia He; Si-Yang Zheng
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

9.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

10.  Influence of liposome charge and composition on their interaction with human blood serum proteins.

Authors:  T Hernández-Caselles; J Villalaín; J C Gómez-Fernández
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.